2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline has been researched along with 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dostert, P; Nagatsu, T; Naoi, M; Niwa, T; Takeda, N; Tatematsu, A; Yoshida, M; Yoshizumi, H | 1 |
1 other study(ies) available for 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
Article | Year |
---|---|
Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Biogenic Amines; Brain Chemistry; Female; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Male; Parkinson Disease; Tetrahydroisoquinolines | 1991 |